Individual differences in schizophrenia

Background Whether there are distinct subtypes of schizophrenia is an important issue to advance understanding and treatment of schizophrenia. Aims To understand and treat individuals with schizophren...

Full description

Bibliographic Details
Main Authors: Edmund T. Rolls, Wenlian Lu, Lin Wan, Hao Yan, Chuanyue Wang, Fude Yang, Yunlong Tan, Lingjiang Li, Hao Yu, Peter F. Liddle, Lena Palaniyappan, Dai Zhang, Weihua Yue, Jianfeng Feng
Format: Article
Language:English
Published: Cambridge University Press 2017-11-01
Series:BJPsych Open
Online Access:https://www.cambridge.org/core/product/identifier/S205647240000243X/type/journal_article
_version_ 1811157103251816448
author Edmund T. Rolls
Wenlian Lu
Lin Wan
Hao Yan
Chuanyue Wang
Fude Yang
Yunlong Tan
Lingjiang Li
Hao Yu
Peter F. Liddle
Lena Palaniyappan
Dai Zhang
Weihua Yue
Jianfeng Feng
author_facet Edmund T. Rolls
Wenlian Lu
Lin Wan
Hao Yan
Chuanyue Wang
Fude Yang
Yunlong Tan
Lingjiang Li
Hao Yu
Peter F. Liddle
Lena Palaniyappan
Dai Zhang
Weihua Yue
Jianfeng Feng
author_sort Edmund T. Rolls
collection DOAJ
description Background Whether there are distinct subtypes of schizophrenia is an important issue to advance understanding and treatment of schizophrenia. Aims To understand and treat individuals with schizophrenia, the aim was to advance understanding of differences between individuals, whether there are discrete subtypes, and how fist-episode patients (FEP) may differ from multiple episode patients (MEP). Method These issues were analysed in 687 FEP and 1880 MEP with schizophrenia using the Positive and Negative Syndrome Scale for (PANSS) schizophrenia before and after antipsychotic medication for 6 weeks. Results The seven Negative Symptoms were correlated with each other and with P2 (conceptual disorganisation), G13 (disturbance of volition), and G7 (motor retardation). The main difference between individuals was in the cluster of seven negative symptoms, which had a continuous unimodal distribution. Medication decreased the PANSS scores for all the symptoms, which were similar in the FEP and MEP groups. Conclusions The negative symptoms are a major source of individual differences, and there are potential implications for treatment.
first_indexed 2024-04-10T05:00:26Z
format Article
id doaj.art-8ccd750777004da0b5459f90a8dc5ff4
institution Directory Open Access Journal
issn 2056-4724
language English
last_indexed 2024-04-10T05:00:26Z
publishDate 2017-11-01
publisher Cambridge University Press
record_format Article
series BJPsych Open
spelling doaj.art-8ccd750777004da0b5459f90a8dc5ff42023-03-09T12:28:44ZengCambridge University PressBJPsych Open2056-47242017-11-01326527310.1192/bjpo.bp.117.005058Individual differences in schizophreniaEdmund T. Rolls0Wenlian Lu1Lin Wan2Hao Yan3Chuanyue Wang4Fude Yang5Yunlong Tan6Lingjiang Li7Hao Yu8Peter F. Liddle9Lena Palaniyappan10Dai Zhang11Weihua Yue12Jianfeng Feng13Department of Computer Science, University of Warwick, Coventry, UK; Oxford Centre for Computational Neuroscience, Oxford, UKCentre for Computational Systems Biology, Fudan University, Shanghai, PR ChinaNational Center for Mathematics and Interdisciplinary Sciences, The Key Laboratory of Systems and Control, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, PR ChinaInstitute of Mental Health, the Sixth Hospital, Peking University, Beijing, PR China; Key Laboratory of Mental Health, Ministry of Health & National Clinical Research Center for Mental Disorders, Peking University, Beijing, PR ChinaBeijing Anding Hospital, Capital Medical University, Beijing, PR ChinaBeijing HuiLongGuan Hospital, Peking University, Beijing, PR ChinaBeijing HuiLongGuan Hospital, Peking University, Beijing, PR ChinaInstitute of Mental Health, The Second Xiangya Hospital of Central South University, Changsha, PR ChinaInstitute of Mental Health, the Sixth Hospital, Peking University, Beijing, PR China; Key Laboratory of Mental Health, Ministry of Health & National Clinical Research Center for Mental Disorders, Peking University, Beijing, PR ChinaCentre for Translational Neuroimaging, Institute of Mental Health, Division of Psychiatry & Applied Psychology, University of Nottingham, Nottingham, UK; Sir Peter Mansfield MR Centre, University of Nottingham, Nottingham, UKDepartment of Psychiatry, University of Western Ontario, London, Ontario, Canada; Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada; Robarts & Lawson Health Research Institutes, London, Ontario, CanadaInstitute of Mental Health, the Sixth Hospital, Peking University, Beijing, PR China; Key Laboratory of Mental Health, Ministry of Health & National Clinical Research Center for Mental Disorders, Peking University, Beijing, PR China; Peking-Tsinghua Joint Center for Life Sciences/PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, ChinaInstitute of Mental Health, the Sixth Hospital, Peking University, Beijing, PR China; Key Laboratory of Mental Health, Ministry of Health & National Clinical Research Center for Mental Disorders, Peking University, Beijing, PR ChinaDepartment of Computer Science, University of Warwick, Coventry, UK Background Whether there are distinct subtypes of schizophrenia is an important issue to advance understanding and treatment of schizophrenia. Aims To understand and treat individuals with schizophrenia, the aim was to advance understanding of differences between individuals, whether there are discrete subtypes, and how fist-episode patients (FEP) may differ from multiple episode patients (MEP). Method These issues were analysed in 687 FEP and 1880 MEP with schizophrenia using the Positive and Negative Syndrome Scale for (PANSS) schizophrenia before and after antipsychotic medication for 6 weeks. Results The seven Negative Symptoms were correlated with each other and with P2 (conceptual disorganisation), G13 (disturbance of volition), and G7 (motor retardation). The main difference between individuals was in the cluster of seven negative symptoms, which had a continuous unimodal distribution. Medication decreased the PANSS scores for all the symptoms, which were similar in the FEP and MEP groups. Conclusions The negative symptoms are a major source of individual differences, and there are potential implications for treatment. https://www.cambridge.org/core/product/identifier/S205647240000243X/type/journal_article
spellingShingle Edmund T. Rolls
Wenlian Lu
Lin Wan
Hao Yan
Chuanyue Wang
Fude Yang
Yunlong Tan
Lingjiang Li
Hao Yu
Peter F. Liddle
Lena Palaniyappan
Dai Zhang
Weihua Yue
Jianfeng Feng
Individual differences in schizophrenia
BJPsych Open
title Individual differences in schizophrenia
title_full Individual differences in schizophrenia
title_fullStr Individual differences in schizophrenia
title_full_unstemmed Individual differences in schizophrenia
title_short Individual differences in schizophrenia
title_sort individual differences in schizophrenia
url https://www.cambridge.org/core/product/identifier/S205647240000243X/type/journal_article
work_keys_str_mv AT edmundtrolls individualdifferencesinschizophrenia
AT wenlianlu individualdifferencesinschizophrenia
AT linwan individualdifferencesinschizophrenia
AT haoyan individualdifferencesinschizophrenia
AT chuanyuewang individualdifferencesinschizophrenia
AT fudeyang individualdifferencesinschizophrenia
AT yunlongtan individualdifferencesinschizophrenia
AT lingjiangli individualdifferencesinschizophrenia
AT haoyu individualdifferencesinschizophrenia
AT peterfliddle individualdifferencesinschizophrenia
AT lenapalaniyappan individualdifferencesinschizophrenia
AT daizhang individualdifferencesinschizophrenia
AT weihuayue individualdifferencesinschizophrenia
AT jianfengfeng individualdifferencesinschizophrenia